BLUE

bluebird bio News

Company Name Stock Ticker Symbol Market Type
bluebird bio Inc BLUE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.83 14.56% 6.53 20:00:00
Open Price Low Price High Price Close Price Prev Close
5.66 5.66 6.57 6.33 5.70
more quote information »

Recent News

Date Time Source Heading
9/26/202207:23TRMNbluebird bio (NASDAQ: BLUE) Shares Slide After Appointing..
9/23/202216:21TRMNBluebird Bio names Katherine Breedis interim CFO
9/20/202223:45TRMNBluebird Bio (BLUE) Receives a Hold from SVB Securities
9/20/202212:45DJNBluebird Bio Shares Up 14%; Raymond James Raises Price..
9/20/202210:55TRMNWilliam Blair Reaffirms Their Hold Rating on Bluebird Bio..
9/19/202207:06EDGARCurrent Report Filing (8-k)
9/19/202206:38DJNBluebird Bio Shares Leap Premarket After FDA Clears Skysona
9/19/202206:25TRMNBlubird bio (NASDAQ:BLUE) Rises on Gene Therapy Approval
9/16/202223:51BWbluebird bio Receives FDA Accelerated Approval for SKYSONA®..
9/12/202207:32EDGARCurrent Report Filing (8-k)
9/12/202207:30BWJason Cole, Chief Strategy and Financial Officer, to Depart..
8/29/202208:00BWbluebird bio Announces September Investor Events
8/25/202217:00EDGARInitial Statement of Beneficial Ownership (3)
8/23/202216:50EDGARStatement of Changes in Beneficial Ownership (4)
8/22/202200:25TRMNWilliam Blair Remains a Hold on Bluebird Bio (BLUE)
8/19/202221:25TRMNBarclays Sticks to Its Hold Rating for Bluebird Bio (BLUE)
8/18/202206:14TRMNBluebird Bio: Stock Price Climbing on FDA Gene Therapy..
8/17/202215:30DJNBluebird Details Plan to Make Zynteglo Accessible in US
8/17/202214:43DJNBluebird's Zynteglo Gene Therapy Approved by FDA -- Update
8/17/202214:32BWbluebird bio Announces U.S. Commercial Infrastructure to..
8/17/202214:30DJNBluebird's Zynteglo Gene Therapy Approved By Food and Drug..
8/17/202214:03BWbluebird bio Announces FDA Approval of ZYNTEGLO®, the First..
8/08/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
8/08/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
8/04/202216:14EDGARQuarterly Report (10-q)
8/04/202216:10EDGARCurrent Report Filing (8-k)
8/04/202216:05BWbluebird bio Reports Second Quarter 2022 Financial Results..
8/01/202216:11EDGARStatement of Ownership (sc 13g)
7/14/202216:18EDGARStatement of Changes in Beneficial Ownership (4)
7/11/202213:13EDGARAmended Statement of Ownership (sc 13g/a)
7/11/202211:42EDGARAmended Statement of Ownership (sc 13g/a)
6/30/202200:56TRMNBluebird Bio (BLUE) Gets a Hold Rating from SVB Securities
6/23/202218:10EDGARStatement of Changes in Beneficial Ownership (4)
6/23/202218:10EDGARStatement of Changes in Beneficial Ownership (4)
6/23/202218:10EDGARStatement of Changes in Beneficial Ownership (4)
6/23/202218:09EDGARStatement of Changes in Beneficial Ownership (4)
6/23/202218:09EDGARStatement of Changes in Beneficial Ownership (4)
6/23/202217:06EDGARCurrent Report Filing (8-k)
6/16/202223:45TRMNWilliam Blair Maintains a Hold Rating on Bluebird Bio (BLUE)
6/10/202215:18BWFDA Advisory Committee Unanimously Supports beti-cel Gene..
6/10/202206:01EDGARCurrent Report Filing (8-k)
6/09/202219:12DJNblueBird bio Says FDA Advisory Committee Unanimously..
6/09/202218:14BWFDA Advisory Committee Unanimously Endorses eli-cel Gene..
6/09/202207:50DJNBluebird Bio Shares Halted as FDA Committee Meets to Discuss..
6/09/202207:05BWbluebird bio stock trading halted today June 9th and..
6/07/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
6/07/202209:20EDGARCurrent Report Filing (8-k)
6/07/202208:36BWbluebird bio Announces Posting of Briefing Documents for..
5/11/202200:30TRMNBluebird Bio (BLUE) Receives a Hold from SVB Securities
5/10/202221:52TRMNRBC Capital Reaffirms Their Hold Rating on Bluebird Bio..


Your Recent History
NASDAQ
BLUE
bluebird b..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now